Rating of The Day: Exova Group (LON:EXO) Stock Rating Maintained by Analysts at Goldman Sachs; The GBX 240.00 Target Indicates 21.67% Potential

November 25, 2016 - By Adrian Mccoy

Exova Group (LON:EXO) Rating

Exova Group (LON:EXO) had its stock rating noted as “Buy” by analysts at Goldman Sachs. Goldman Sachs currently has a GBX 240.00 target price on the 493.98 million GBP market cap company or 21.67% upside potential. This was shown in analysts report on Friday, 25 November.

Exova Group Plc (LON:EXO) Ratings Coverage

Out of 6 analysts covering Exova Group Plc (LON:EXO), 6 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 240 is the highest target while GBX 158 is the lowest. The GBX 216 average target is 9.51% above today’s (GBX 197.25) stock price. Exova Group Plc has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of Exova Group Plc (LON:EXO) earned “Buy” rating by Shore Capital on Thursday, March 3. On Thursday, September 1 the stock rating was maintained by Barclays Capital with “Overweight”. Investec maintained Exova Group Plc (LON:EXO) rating on Wednesday, November 11. Investec has “Buy” rating and GBX 210 price target. Shore Capital maintained Exova Group Plc (LON:EXO) on Monday, July 4 with “Buy” rating. The stock of Exova Group Plc (LON:EXO) earned “Buy” rating by Shore Capital on Tuesday, February 23. Peel Hunt maintained Exova Group Plc (LON:EXO) on Wednesday, November 11 with “Hold” rating. Peel Hunt maintained Exova Group Plc (LON:EXO) on Friday, January 15 with “Hold” rating. The stock has “Buy” rating given by Goldman Sachs on Thursday, September 1. Barclays Capital maintained the shares of EXO in a report on Friday, March 4 with “Overweight” rating. The firm has “Buy” rating by Shore Capital given on Thursday, September 22.

It is down 23.28% since April 27, 2016 and is uptrending. It has outperformed by 17.87% the S&P500.

Exova Group plc is a United Kingdom well-known provider of testing and advisory services. The company has a market cap of 493.98 million GBP. The Firm is a laboratory testing firm operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. It has a 24.17 P/E ratio. The Company’s divisions include Europe, Americas and Rest of World.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>